The team Partenariats gathers people with various backgrounds, multiple experiences and complementary expertises:
European and international affairs manager/grant office
Constance has obtained her PharmD from Université Paris Descartes in 2006. She has worked more than 8 years as Grants officer in several private and public institutions in France and in the USA. She brings deep expertise in prospecting, setting up, submitting and monitoring competitive national, European and International projects (PIA, H2020, MSCA, NIH, international foundations, etc.).
She has joined the BIOASTER Development & Partnerships team in March 2021 as Grants Office Manager, European and International Affairs.
Sara FRÖJDÖ, Strategic Partnership Manager – Diagnostic
After a Masters degree in Genetics from Helsinki University, Sara obtained a PhD in molecular biology from University of Lyon (INSERM/INRA). Then, she spent 10 years at Alcimed, in international innovation and new business development consulting. This has allowed her to work with multiple key decision makers from both big life science industries, SMEs and start-ups.
She joined our Strategic Partnership office in Diagnostic program since November 2018.
Christine POHL, Strategic Partnership Manager – Vaccines
Christine holds a PhD in the field of virology from Würzburg University in Germany and has been a researcher at the P4 laboratory Jean Mérieux / École Normale Supérieure in Lyon. Her research has been focused on the study of mechanisms of infection employed measles and Nipah virus.
Thereafter, Christine has worked for ten years in strategy consulting in the healthcare sector, providing consultancy to the biggest players in the pharmaceutical industry in domains as varied as market access, government affairs, marketing and R&D.
Today, she joins our strategic partnership office for the vaccines program where she brings into play her experience and passion in the fight against infectious diseases.
Kristin THOMPSON, Strategic Partnership Manager – Microbiota
Kristin holds a degree in Biology from the University of North Carolina-at Chapel Hill with a specialty in Genetics and a Doctorate in Molecular Medicine from the University of Ulm, Germany.
With more than 10 years of research experience in the public and private sectors, specifically in drug discovery and the transition of those targets to Phase 1 clinical trials, Kristin has a clear understanding of what it takes to for an invention to go from the bench to the clinic. Following her years as a researcher, Kristin took her international experience and scientific expertise to business development roles in which she managed out-licensing with several top pharma companies and in-licensing with TTOs and biotechs. Furthermore, she was responsible for defining the business strategy for the R&D department of a major global company and consulted for start-ups on partnering assets including fundraising, due diligence and the pre-clinical and manufacturing milestones.
Kristin brings to the microbiome program her knowledge developing and partnering innovative assets and how to get these into the hands of patients, at the precise moment that this is becoming a reality for the exciting microbiome domain.
Alice ROCHARD, Strategic Partnership Manager – Antimicrobials
Alice graduated in 2010 as a chemical engineer from Chimie ParisTech, one of the France’s top ranking chemistry engineering school. She holds a PhD in DNA vaccines from Pierre and Marie Curie University.
Passionate about innovation for health, she has an extensive expertise in public-private partnership management. She has worked for 6 years in a technology transfer office to support valorization of innovative biomedical research projects and high potential technologies through business development activities. Committed to promote translational research, her latest position was to coordinate development of IVD solutions for control of antibiotic resistance in low and medium income countries.
Today she joins our strategic partnership team for the antimicrobials program.